Zybio Inc.

13/08/2026

📢Another Milestone in Clinical Chemistry – from Zybio!
We are proud to announce that our scientific abstract has been accepted for presentation at ADLM — a testament to our commitment to advancing diagnostic innovation. Our study introduces a novel oligomeric antibody-based immunoturbidimetric assay for HbA1c detection, addressing the key limitations of traditional methods while delivering performance comparable to the HPLC gold standard.

HPLC remains the gold standard for HbA1c testing, but it is slow and costly. Traditional immunoturbidimetric assays offer speed but compromise on stability and complexity. Our oligomeric antibody technology bridges this gap — delivering HPLC-comparable accuracy on an automated, high-speed platform that is practical, cost-effective, and ready for routine diagnostics.

In a study of 194 clinical samples, our kit demonstrated excellent consistency with the HPLC gold standard (Arkray HA-8180), with a correlation coefficient r = 0.9928— well above the required threshold of 0.975. While traditional immunoturbidimetric assays show low-end repeatability CV of 7%, our kit achieves a remarkable CV < 2.5% — delivering the reliability that clinicians and laboratories demand. After 30 days of in-use stability, our reagent showed a relative deviation of < 5% , compared to >7% deviation for traditional methods after just 15 days. That means less waste, fewer recalibrations, and greater confidence in every run.
Curious about more details? Follow us and get in touch with Zybio Team 🙌

10/08/2026

We’ve been upgraded—small size, scalable modular, and CE-IVDR approved! EXB 60 Blood Culture System is not just a smaller footprint, but a more scalable design flexible to your needs.
⚡Fast & Sensitive: Positive in 3 hours with 1 CFU/bottle detection limit for earlier intervention.
🧫Broad & Powerful: Covers 90%+ pathogens with multi-resin antibiotic neutralization and optimized culture media for enhanced recovery of fastidious microorganisms, including direct CSF culture.
📲Smart & Connected: 60-600+ bottle modular scalability, automatic barcode scanning, blood volume detection, real-time alerts, LIS integration, and centralized data management.
Curious about more details? Send us a DM to get in touch with Zybio Team🙌

06/08/2026

📢New Data from Zybio at ADLM!
Lipemic samples and cross-platform variability have long plagued lipid testing. Our new study introduces a multi-dimensional lipid dissociation technology that tackles both—ensuring accuracy even in turbid samples, and consistent results across different analyzers.

We tested 6 core lipids (HDL-C, LDL-C, CHOL, TG, APOA1, APOB) across 5 systems (Three Zybio EXC series, the mainstream international clinical chemistry analyzer A, the mainstream international clinical chemistry analyzer B) vs. the mainstream international clinical chemistry analyzer C reference, using 660 samples (incl. 180 lipemic samples).
✅ Across 5 systems: r > 0.995 | concordance > 98%
✅ vs. mainstream international clinical chemistry analyzer C reference: r > 0.992 | concordance > 95%
✅ Lipemic samples: Zero clinically discrepant results.

Our technology effectively breaks down chylomicrons and eliminates matrix interference—delivering reliable results regardless of sample turbidity or instrument brand. Backed by Zybio’s international traceability framework, this ensures your lab gets true, standardised cardiovascular risk assessment, every time.
Curious about more details? Follow us and get in touch with Zybio Team 🙌

04/08/2026

HIL interference to optical method? Limited sensitivity of mechanical method to subtle clots? To figure out the persistent challenges in routine coagulation testing, our EXT 9800 integrates a tri-modal platform—Optical, Mechanical, and CSM (Cell-scale Superparamagnetic Particles)—to overcome these limitations.

The results speak volumes:
✅ Routine samples (n=234): Excellent inter-method consistency across APTT, PT, and TT (r > 0.975).
✅ The game-changer CSM: In a challenging sample where Optical gave erratic TT results (30.7–38.2s) and Mechanical returned "no result," CSM delivered a stable, definitive TT of 37.5s (CV ~2.0%)
✅ Visible pathophysiological process: clarifying what conventional methods missed

This tri-modal approach doesn't just run tests; it enhances diagnostic confidence in complex coagulation scenarios, turning ambiguous results into clear answers.
Curious about more details? Follow us and get in touch with Zybio Team 🙌

01/08/2026

During July 28-30, 2026, ADLM 2026 witnessed thousands of visits to Zybio's comprehensive laboratory diagnostic solutions with flagships from our 9 product platforms at booth 2281.
📷 Check out the booth highlights in the video below! And if we missed you at the show, we'd still love to connect—reach out anytime: https://youtu.be/YfwL4v4jSb0

Covering hematology, coagulation, urinalysis, clinical chemistry, CLIA, POCT, molecular, mass spectrometry and microbiology, Zybio’s expansive portfolio is designed to provide a whole-range solution for our customers and end-users. We are cheered to have your trust and we aim to bring you more flagships like EXS 2600 MALDI-TOF MS System with dual identification in one platform, EXI 1820 automated CLIA analyzer with exceptional speed, and EXZ 8000 series 6-diff CBC+CRP+SAA integrated analyzer for enhanced accuracy in knotty samples.

As we pack up, we carry forward the same commitment that guides everything we do: "Dedication to Accuracy." But beyond precision, we're doubling down on a customer‑centric approach—expanding our service capabilities to deliver more comprehensive, efficient, and impactful solutions for healthcare providers, all to ultimately protect patient health.

During July 28-30, 2026, ADLM 2026 witnessed thousands of visits to...

27/07/2026

It’s tomorrow! What may you expect at Zybio booth 2281 at ADLM 2026 during July 28-30? The debut of LC-EXQ 3600 Triple Quadrupole Mass Spectrometry System built on 1,500+ units of proven manufacturing and IP from Xiamen University
✅ 180° curved collision cell with push‑pull ion acceleration → lower noise, faster MRM switching
✅ Ion transmission noise‑filtering → superior contamination resistance, less downtime
✅ Hybrid‑field optimized transfer → >10× ion transmission gain, better reproducibility
✅ One‑click automated software → easy operation from start to finish
Come to our booth 2281 to explore more details👋

26/07/2026

2 days to go! What may you expect at Zybio booth 2281 at ADLM 2026 during July 28-30? EXS 2600 MALDI-TOF MS system combining real spectra + genome-based prediction to realize dual identification with one platform
✅PMF database + genome-based predictive database
✅ Expands coverage to 14,000+ species
✅ Up to 99% genus-level accuracy
✅ Cross-validation for higher confidence
Come to our booth 2281 to explore more details

25/07/2026

3 days to go! What may you expect at Zybio booth 2281 at ADLM 2026 during July 28-30? EXI 1820 Automated CLIA Analyzer, not just fast, but exceptionally precise
✅50-sample tray capacity with dedicated STAT port—aspiration in 30 seconds
✅24/7 uninterrupted refrigerated conditions for reagents tray—reagents stay stable, always ready
✅Results that stand up to scrutiny—traceable to global standards
✅Ready-to-use QCs and calibrators—time relocated and precision made
Come to our booth 2281 to explore more details👋

24/07/2026

4 days to go! What may you expect at Zybio booth 2281 at ADLM 2026 during July 28-30? EXZ 8000 Series 6-Diff + CRP + SAA Integrated Hematology Analyzer, providing more reliable results with new-generation nucleic acid fluorescence technology
✅Enhanced PLT-O method ensures accurate platelet counts, free from interference by non-platelet particles such as small red blood cells or cellular debris
✅Panoramic Mode allows intelligent analysis for low WBC counts and 8-fold multiplication for low PLT counts
✅Automated micro-volume whole blood sampling: Get CBC + CRP + SAA results from a single tube
Come to our booth 2281 to explore more details👋

21/07/2026

Accepted! In ADLM 2026, Zybio has 3 abstracts accepted as posters displayed:
📆July 28th, A147
Zybio HbA1c assay shows high correlation with HPLC gold standard: R²=0.9928

📆July 29th, B015
Compared with globally leading brands, Zybio's lipids panel based on clinical chemistry platform shows high reliability (>95% consistency, r>0.992)

📆July 29th, A231
APTT, PT, and TT testing based on Zybio's EXT 9800 Tri-Modal Coagulation Detection, shows r>0.975 with 97.5% diagnostic concordance

You are also welcomed to come to Zybio's booth 2281 to discuss more details with our team regarding the other 3 accepted abstracts and further innovative technology upgrades
Curious about more details? Follow us and get in touch with Zybio Team🙌